| Results summary | View all lists in GO:BiolProc | View all genes in D07XB.profile.ud50 |
|
Development of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. enrichment: 1.75-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 213792_S_AT | INSR | D | E | P | S | insulin receptor | |||||||
| 209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
| 218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
| 208960_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 | ||||||||
| 201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
| 207147_AT | DLX2 | D | R | distal-less homeobox 2 | |||||||||
| 208961_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 | ||||||||
| 209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
| 205032_AT | ITGA2 | D | X | C | S | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | |||||||